Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
intraoperative hemodynamic instability
paraganglioma
phenoxybenzamine
pheochromocytoma
postoperative outcomes
preparation duration
secretory phenotype
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
01
2023
accepted:
28
03
2023
medline:
9
5
2023
pubmed:
8
5
2023
entrez:
8
5
2023
Statut:
epublish
Résumé
Resection of pheochromocytoma and paraganglioma (PPGL) carries risks with perioperative hemodynamic instability. Phenoxybenzamine (PXB) is a commonly used α-blockade to prevent it. It is unclear whether lengthening the preoperative duration of PXB is better for hemodynamic stability and postoperative outcomes. Furthermore, different types of catecholamines have varying effects on perioperative hemodynamics. Thus, our study aimed to investigate the impact of the duration of preoperative preparation with PXB and secretory phenotypes of the patients on intraoperative hemodynamic stability and postoperative complications in PPGL. Between Dec 2014 and Jan 2022, 166 patients with PPGL were operated on by the same team at Sun Yat-sen Memorial Hospital. They were divided into group A(1-14d), Group B(15-21d), and Group C(>21d) based on the duration of management with PXB and into the adrenergic and the noradrenergic phenotype group based on secretory profiles. Data on intraoperative hemodynamics and postoperative outcomes were collected and compared among groups. A total of 96 patients occurred intraoperative hemodynamic instability, and 24 patients had 29 postoperative complications related to the surgery. Among the 145 patients treated with PXB, no significant differences were found in the cumulative time outside the target blood pressure(6.67%[0-17.16%] A preoperative duration of nearly 14 days with PXB is sufficient for ensuring intraoperative hemodynamic stability in PPGL. And lengthening the preparation duration may not provide additional benefits in the era of widespread application and advanced techniques of laparoscopic surgery. Additionally, patients with the adrenergic phenotype are more prone to intraoperative hemodynamic instability than the noradrenergic phenotype. Thus, more attention should be given to the adrenergic phenotype during surgery.
Identifiants
pubmed: 37152936
doi: 10.3389/fendo.2023.1139015
pmc: PMC10154584
doi:
Substances chimiques
Phenoxybenzamine
0TTZ664R7Z
Metanephrine
5001-33-2
Norepinephrine
X4W3ENH1CV
Adrenergic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1139015Informations de copyright
Copyright © 2023 Yao, Guo, Fan, Lin, Wang and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Endocrinol (Oxf). 2017 Mar;86(3):309-314
pubmed: 27864838
Br J Anaesth. 2017 Feb;118(2):182-189
pubmed: 28100521
J Allergy Clin Immunol. 2000 Nov;106(5):896-903
pubmed: 11080712
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 31714582
Endocrine. 2022 May;76(2):426-433
pubmed: 35426588
Br J Surg. 1979 Jul;66(7):456-65
pubmed: 466037
Ann Surg. 1999 Jun;229(6):755-64; discussion 764-6
pubmed: 10363888
J Clin Endocrinol Metab. 2001 Apr;86(4):1480-6
pubmed: 11297571
J Natl Compr Canc Netw. 2018 Jun;16(6):693-702
pubmed: 29891520
Surg Today. 2016 Jun;46(6):668-85
pubmed: 26289837
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
Cancers (Basel). 2022 Feb 12;14(4):
pubmed: 35205664
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):278-282
pubmed: 28918451
Br J Surg. 2020 Jan;107(2):e170-e178
pubmed: 31903598
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102
pubmed: 17237836
Endocr Connect. 2021 Jan;10(1):92-101
pubmed: 33320109
World J Surg. 2014 Mar;38(3):716-23
pubmed: 24233658
Ann Surg Oncol. 2014 Nov;21(12):3865-71
pubmed: 24939623
Gland Surg. 2021 Mar;10(3):892-900
pubmed: 33842234
Ann Surg Oncol. 2015 Dec;22(13):4175-80
pubmed: 25822781
J Clin Med. 2020 Jul 30;9(8):
pubmed: 32751501
Eur J Anaesthesiol. 2008 Jun;25(6):508-10
pubmed: 18447966
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Ann Surg Oncol. 2017 Jan;24(1):244-250
pubmed: 27561909
Eur J Anaesthesiol. 2019 Apr;36(4):290-296
pubmed: 30624247
J Clin Endocrinol Metab. 2020 Jun 1;105(6):
pubmed: 32222768
Biomed Res Int. 2019 Nov 16;2019:2613137
pubmed: 31828097
J Clin Endocrinol Metab. 2011 Feb;96(2):375-84
pubmed: 21147885
J Clin Endocrinol Metab. 2013 Mar;98(3):1100-6
pubmed: 23408574
Endocrine. 2018 Dec;62(3):566-575
pubmed: 30220006
Clin Chem. 2005 Apr;51(4):735-44
pubmed: 15718487
Hum Mutat. 2010 Jan;31(1):41-51
pubmed: 19802898
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5170-5180
pubmed: 31009053
Endocrinol Metab Clin North Am. 2011 Jun;40(2):295-311, vii
pubmed: 21565668
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1223-33
pubmed: 18854424
Front Endocrinol (Lausanne). 2021 Mar 11;12:647610
pubmed: 33790869